Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Swetlana Wunder
Observed name:
Wunder, Swetlana
Institution:
Tubulis (Germany)
Observed institutions:
Center for Integrated Protein Science Munich,
Tubulis (Germany),
Ludwig-Maximilians-Universität München
ORCID:
0009-0007-5578-4008
Observed ORCID:
0009-0007-5578-4008
OpenAlex ID:
A5073264375
3,3′‐Bi(1,2,4‐oxadiazoles) Featuring the Fluorodinitromethyl and Trinitromethyl Groups
2014
·
Marcos A. Kettner
, Konstantin Karaghiosoff
, et al.
·
Chemistry - A European Journal
·
160
Structural Basis for EarP-Mediated Arginine Glycosylation of Translation Elongation Factor EF-P
2017
·
Ralph Krafczyk
, Jakub Macošek
, et al.
·
mBio
·
40
PDF
Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2023
·
Saskia Schmitt
, Paul Machui
, et al.
·
Molecular Cancer Therapeutics
·
25
PDF
Expanding the payload scope in antibody-drug conjugates by delivery of hydroxy-containing drugs through self-immolative phosphoramidates
2026
·
Philipp Ochtrop
, Anil P. Jagtap
, et al.
·
Nature Communications
·
9
PDF
A set of rhamnosylation-specific antibodies enables detection of novel protein glycosylations in bacteria
2020
·
Daniel Gast
, Franziska Koller
, et al.
·
Organic & Biomolecular Chemistry
·
8
One-Pot Synthesis of Functionalized β-Fluoroalkylated Mannich-Type Products from N-Aryl N,O-Acetals
2016
·
Carl Deutsch
, Anja Hoffmann-Röder
, et al.
·
Synthesis
·
3
Supplementary Data from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Supplementary figure 3 from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Supplementary figure 2 from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Additional experimental procedures from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Supplementary Data from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Supplementary figure 1 from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Supplementary figure 6 from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
ADC characterization from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Data from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Organic synthesis from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Supplementary figure 4 from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Supplementary figure 5 from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Supplementary figure 1 from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Supplementary figure 7 from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
Data from Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
2024
·
Saskia Schmitt
, Paul Machui
, et al.
ChemInform Abstract: One‐Pot Synthesis of Functionalized β‐Fluoroalkylated Mannich‐Type Products from N‐Aryl N,O‐Acetals.
2016
·
Swetlana Wunder
, Amrei Deutsch
, et al.
·
ChemInform
N‐アリールN,O‐アセタールからの官能基化β‐フルオロアルキル化Mannich型生成物のワンポット合成
2016
·
Swetlana Wunder
, Deutsch Amrei
, et al.
Synthesis and characterization of alkylated trinitromethyl- and fluorodinitromethyl-tetrazoles
2014
·
Johannes Feierfeil
, Marcos A. Kettner
, et al.
CCDC 963149: Experimental Crystal Structure Determination
2014
·
Kettner, Marcos A.
, Karaghiosoff, Konstantin
, et al.
·
The Cambridge Structural Database
Show more works
View as search
Works count:
28
Citation count:
245
H-index:
5
I10-index:
3
Year
Topic
Type